Lombard Medical (OTCMKTS: EVARF) is one of 80 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its rivals? We will compare Lombard Medical to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, dividends, earnings and analyst recommendations.
Institutional & Insider Ownership
40.1% of Lombard Medical shares are owned by institutional investors. Comparatively, 65.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 11.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
This is a breakdown of current ratings and target prices for Lombard Medical and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Lombard Medical Competitors||208||1205||2685||86||2.63|
As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.35%. Given Lombard Medical’s rivals higher probable upside, analysts clearly believe Lombard Medical has less favorable growth aspects than its rivals.
Valuation & Earnings
This table compares Lombard Medical and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Lombard Medical||$12.17 million||-$31.03 million||-0.13|
|Lombard Medical Competitors||$975.11 million||$120.37 million||213.05|
Lombard Medical’s rivals have higher revenue and earnings than Lombard Medical. Lombard Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This table compares Lombard Medical and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Lombard Medical Competitors||-126.55%||-39.89%||-10.83%|
Risk and Volatility
Lombard Medical has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Lombard Medical’s rivals have a beta of 0.96, indicating that their average share price is 4% less volatile than the S&P 500.
Lombard Medical rivals beat Lombard Medical on 5 of the 9 factors compared.
About Lombard Medical
Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.
Receive News & Ratings for Lombard Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lombard Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.